Back to Search
Journal ArticleOpen Access

Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study

Author Affiliations
The University of Sydney, Population Health Research Institute, Westmead Hospital, The George Institute for Global Health, ...
Published InThe Lancet Diabetes & Endocrinology
Year2018
Citations199

Abstract

BACKGROUND Data are scarce on the availability and affordability of essential medicines for diabetes. Our aim was to examine the availability and affordability of metformin, sulfonylureas, and insulin across multiple regions of the world and explore the effect of these on medicine use. METHODS In the Prospective Urban Rural Epidemiology (PURE) study, participants aged 35-70 years (n=156 625) were recruited from 110 803 households, in 604 communities and 22 countries; availability (presence of any dose of medication in the pharmacy on the day of audit) and medicine cost data were collected from pharmacies with the Environmental Profile of a Community's Health audit tool. Our primary analysis was to describe the availability and affordability of metformin and insulin and also commonly…
View at Publisher

BORR does not host full-text PDFs. The button above takes you to the original publisher.